PE20011005A1 - COMBINATIONS OF A PHOSPHODIESTERASE 4 INHIBITOR AND A STEROID ANTI-INFLAMMATORY FOR THE TREATMENT OF PULMONARY DISEASES - Google Patents
COMBINATIONS OF A PHOSPHODIESTERASE 4 INHIBITOR AND A STEROID ANTI-INFLAMMATORY FOR THE TREATMENT OF PULMONARY DISEASESInfo
- Publication number
- PE20011005A1 PE20011005A1 PE2000001168A PE0011682000A PE20011005A1 PE 20011005 A1 PE20011005 A1 PE 20011005A1 PE 2000001168 A PE2000001168 A PE 2000001168A PE 0011682000 A PE0011682000 A PE 0011682000A PE 20011005 A1 PE20011005 A1 PE 20011005A1
- Authority
- PE
- Peru
- Prior art keywords
- phosphodiesterase
- inhibitor
- pulmonary diseases
- inflammatory
- combinations
- Prior art date
Links
- 208000019693 Lung disease Diseases 0.000 title abstract 2
- 229940123932 Phosphodiesterase 4 inhibitor Drugs 0.000 title 1
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
- 239000002587 phosphodiesterase IV inhibitor Substances 0.000 title 1
- 150000003431 steroids Chemical class 0.000 title 1
- MSYGAHOHLUJIKV-UHFFFAOYSA-N 3,5-dimethyl-1-(3-nitrophenyl)-1h-pyrazole-4-carboxylic acid ethyl ester Chemical compound CC1=C(C(=O)OCC)C(C)=NN1C1=CC=CC([N+]([O-])=O)=C1 MSYGAHOHLUJIKV-UHFFFAOYSA-N 0.000 abstract 1
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 abstract 1
- 101100296719 Caenorhabditis elegans pde-4 gene Proteins 0.000 abstract 1
- 102000011017 Type 4 Cyclic Nucleotide Phosphodiesterases Human genes 0.000 abstract 1
- 108010037584 Type 4 Cyclic Nucleotide Phosphodiesterases Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000003470 adrenal cortex hormone Substances 0.000 abstract 1
- 229960004495 beclometasone Drugs 0.000 abstract 1
- RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical compound C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 abstract 1
- 229960002714 fluticasone Drugs 0.000 abstract 1
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 229960002744 mometasone furoate Drugs 0.000 abstract 1
- WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 abstract 1
- 229960002117 triamcinolone acetonide Drugs 0.000 abstract 1
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE AL USO DE UNA COMBINACION QUE COMPRENDE:UN INHIBIDOR DE FOSFODIESTERASA 4 (PDE 4) TAL COMO EL ACIDO CIS-4-CIANO-(3-CICLOPENTILOXI-4-METOXIFENIL)CICLOHEXANO-1-CARBOXILICO Y UN CORTICOIDE TAL COMO DEXAMETASONA, FLUTICASONA, BECLOMETASONA, BUDENOSINA, FLUNICOLIDA, FUROATO DE MOMETASONA, ACETONIDO DE TRIAMCINOLONA; LOS QUE SE ADMINISTRAN JUNTOS O POR SEPARADO. LA COMBINACION PUEDE SER UTIL PARA PREVENIR O REDUCIR ENFERMEDADES PULMONARESIT REFERS TO THE USE OF A COMBINATION THAT INCLUDES: A PHOSPHODIESTERASE 4 (PDE 4) INHIBITOR SUCH AS CIS-4-CYANE- (3-CYCLOPENTILOXY-4-METOXYPHENYL) CYCLOHEXAN-1-CARBOXAMYLONE ACID, AND A CORTICOID THAX FLUTICASONE, BECLOMETASONE, BUDENOSINE, FLUNICOLIDE, MOMETASONE FUROATE, TRIAMCINOLONE ACETONIDE; THOSE THAT ARE ADMINISTERED TOGETHER OR SEPARATELY. THE COMBINATION MAY BE USEFUL TO PREVENT OR REDUCE PULMONARY DISEASES
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16315899P | 1999-11-02 | 1999-11-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20011005A1 true PE20011005A1 (en) | 2001-09-28 |
Family
ID=22588737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2000001168A PE20011005A1 (en) | 1999-11-02 | 2000-11-02 | COMBINATIONS OF A PHOSPHODIESTERASE 4 INHIBITOR AND A STEROID ANTI-INFLAMMATORY FOR THE TREATMENT OF PULMONARY DISEASES |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP1225866A4 (en) |
| JP (1) | JP2003513028A (en) |
| KR (1) | KR20020057988A (en) |
| CN (1) | CN1387404A (en) |
| AP (1) | AP2002002496A0 (en) |
| AR (1) | AR029189A1 (en) |
| AU (1) | AU1357501A (en) |
| BG (1) | BG106748A (en) |
| BR (1) | BR0015270A (en) |
| CA (1) | CA2388333A1 (en) |
| CO (1) | CO5261512A1 (en) |
| CZ (1) | CZ20021512A3 (en) |
| DZ (1) | DZ3225A1 (en) |
| EA (1) | EA200200518A1 (en) |
| EC (1) | ECSP003747A (en) |
| HK (1) | HK1049107A1 (en) |
| HU (1) | HUP0203152A3 (en) |
| IL (1) | IL149367A0 (en) |
| MA (1) | MA26841A1 (en) |
| MX (1) | MXPA02004350A (en) |
| NO (1) | NO20022057L (en) |
| OA (1) | OA12076A (en) |
| PE (1) | PE20011005A1 (en) |
| PL (1) | PL355261A1 (en) |
| SK (1) | SK7592002A3 (en) |
| TR (1) | TR200201211T2 (en) |
| TW (1) | TWI242431B (en) |
| WO (1) | WO2001032127A2 (en) |
| ZA (1) | ZA200203435B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL160271A0 (en) * | 2001-09-19 | 2004-07-25 | Altana Pharma Ag | Pharmaceutical compositions containing pde4-inhibitors and nsaid |
| CZ2004516A3 (en) * | 2001-10-31 | 2004-08-18 | Merckápatentágmbh | Type 4 phosphodiesterase inhibitor, combinations thereof with other drugs and its use |
| UA82323C2 (en) * | 2002-08-09 | 2008-04-10 | Меда Фарма Гмбх & Ко. Кг | Novel combination of a glucocorticoid and pde-inhibitor for the treatment of respiratory diseases, allergic diseases, asthma and chronic obstructive pulmonary diseases |
| TW200410923A (en) * | 2002-10-17 | 2004-07-01 | Ono Pharmaceutical Co | Therapeutic agent for chronic obstructive pulmonary disease |
| CN1767828A (en) * | 2003-03-31 | 2006-05-03 | 协和发酵工业株式会社 | pharmaceutical composition |
| US20050026883A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
| EP1810692A1 (en) * | 2004-10-13 | 2007-07-25 | Kyowa Hakko Kogyo Co., Ltd. | Remedies/preventives for chronic skin disease |
| RU2008119322A (en) * | 2005-10-19 | 2009-11-27 | Рэнбакси Лабораториз Лимитед (In) | COMPOSITIONS OF PHOSPHODIESTHESIS INHIBITORS TYPE IV |
| ES2702753T3 (en) | 2010-01-05 | 2019-03-05 | Microdose Therapeutx Inc | Inhalation device |
| WO2015063669A1 (en) | 2013-10-30 | 2015-05-07 | Wockhardt Limited | Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995000139A1 (en) * | 1993-06-18 | 1995-01-05 | Smithkline Beecham Corporation | Compounds |
| DE4332041C2 (en) * | 1993-09-21 | 1997-12-11 | Rentschler Arzneimittel | Use of pentoxifylline in certain lung diseases |
| PE44995A1 (en) * | 1994-01-27 | 1995-12-18 | Schering Corp | MOMETASONE FUROATE FOR THE TREATMENT OF LUNG DISEASES AND RESPIRATORY TRACT |
| SE9801368D0 (en) * | 1998-04-20 | 1998-04-20 | Astra Ab | New use |
-
2000
- 2000-10-31 EC EC2000003747A patent/ECSP003747A/en unknown
- 2000-10-31 AR ARP000105742A patent/AR029189A1/en not_active Application Discontinuation
- 2000-11-01 KR KR1020027005609A patent/KR20020057988A/en not_active Ceased
- 2000-11-01 HU HU0203152A patent/HUP0203152A3/en unknown
- 2000-11-01 WO PCT/US2000/030113 patent/WO2001032127A2/en not_active Ceased
- 2000-11-01 DZ DZ003225A patent/DZ3225A1/en active
- 2000-11-01 PL PL00355261A patent/PL355261A1/en not_active Application Discontinuation
- 2000-11-01 AP APAP/P/2002/002496A patent/AP2002002496A0/en unknown
- 2000-11-01 JP JP2001534335A patent/JP2003513028A/en active Pending
- 2000-11-01 MX MXPA02004350A patent/MXPA02004350A/en unknown
- 2000-11-01 BR BR0015270-6A patent/BR0015270A/en not_active IP Right Cessation
- 2000-11-01 SK SK759-2002A patent/SK7592002A3/en unknown
- 2000-11-01 CZ CZ20021512A patent/CZ20021512A3/en unknown
- 2000-11-01 HK HK02109234.5A patent/HK1049107A1/en unknown
- 2000-11-01 EA EA200200518A patent/EA200200518A1/en unknown
- 2000-11-01 OA OA1200200124A patent/OA12076A/en unknown
- 2000-11-01 CN CN00815265A patent/CN1387404A/en active Pending
- 2000-11-01 AU AU13575/01A patent/AU1357501A/en not_active Abandoned
- 2000-11-01 TR TR2002/01211T patent/TR200201211T2/en unknown
- 2000-11-01 IL IL14936700A patent/IL149367A0/en unknown
- 2000-11-01 CA CA002388333A patent/CA2388333A1/en not_active Abandoned
- 2000-11-01 EP EP00975533A patent/EP1225866A4/en not_active Withdrawn
- 2000-11-02 PE PE2000001168A patent/PE20011005A1/en not_active Application Discontinuation
- 2000-11-02 CO CO00083427A patent/CO5261512A1/en not_active Application Discontinuation
- 2000-11-22 TW TW089123039A patent/TWI242431B/en not_active IP Right Cessation
-
2002
- 2002-04-30 NO NO20022057A patent/NO20022057L/en not_active Application Discontinuation
- 2002-04-30 ZA ZA200203435A patent/ZA200203435B/en unknown
- 2002-05-02 MA MA26621A patent/MA26841A1/en unknown
- 2002-05-29 BG BG106748A patent/BG106748A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA02004350A (en) | 2002-11-07 |
| AP2002002496A0 (en) | 2002-06-30 |
| JP2003513028A (en) | 2003-04-08 |
| NO20022057D0 (en) | 2002-04-30 |
| WO2001032127A2 (en) | 2001-05-10 |
| HK1049107A1 (en) | 2003-05-02 |
| ECSP003747A (en) | 2002-05-23 |
| CN1387404A (en) | 2002-12-25 |
| CA2388333A1 (en) | 2001-05-10 |
| HUP0203152A3 (en) | 2004-06-28 |
| OA12076A (en) | 2006-05-04 |
| IL149367A0 (en) | 2002-11-10 |
| BR0015270A (en) | 2002-06-18 |
| AU1357501A (en) | 2001-05-14 |
| SK7592002A3 (en) | 2002-11-06 |
| HUP0203152A2 (en) | 2003-01-28 |
| EP1225866A4 (en) | 2004-04-21 |
| TR200201211T2 (en) | 2002-08-21 |
| DZ3225A1 (en) | 2001-05-10 |
| NO20022057L (en) | 2002-06-27 |
| KR20020057988A (en) | 2002-07-12 |
| BG106748A (en) | 2003-02-28 |
| ZA200203435B (en) | 2003-06-25 |
| MA26841A1 (en) | 2004-12-20 |
| EP1225866A2 (en) | 2002-07-31 |
| AR029189A1 (en) | 2003-06-18 |
| PL355261A1 (en) | 2004-04-05 |
| EA200200518A1 (en) | 2002-10-31 |
| CO5261512A1 (en) | 2003-03-31 |
| TWI242431B (en) | 2005-11-01 |
| CZ20021512A3 (en) | 2003-04-16 |
| WO2001032127A3 (en) | 2001-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR032471A1 (en) | DERIVED FROM ANDROSTAN AND SOLVATOS OF THE SAME, ITS USE FOR THE MANUFACTURE OF MEDICINES, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, PROCESSES TO PREPARE SUCH DERIVATIVES, USEFUL INTERMEDIARIES IN THE PREPARATION OF SUCH DERIVATIVES, PROCESSES TO PREPARE SUCH INTERMEDIATES | |
| UY26977A1 (en) | IMIDAZOL COMPOUNDS CONDENSED WITH ARILO OR HETEROARILO AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS | |
| HRP20050781B1 (en) | METHODS AND PHARMACEUTICAL MIXTURES FOR RELIABLE ACHIEVEMENT OF ACCEPTABLE TESTOSTERONE LEVELS IN SERUM | |
| TW200837074A (en) | Extended triterpene derivatives | |
| PE34998A1 (en) | A NASAL ATOMIZER CONTAINING AN INTRANASAL STEROID AND AN ANTIHISTAMINE | |
| CO5140098A1 (en) | COMBINATIONS OF A BETRA-2 AGONIST AND A STEROID, ITS USE FOR THE TREATMENT OF INFLAMMATORY OR OBSTRUCTIVE DISEASES OF THE AIRWAYS | |
| BR0111206A (en) | Arylmethylamine derivatives for use as tryptase inhibitors | |
| CL2004001170A1 (en) | INHALABLE PHARMACEUTICAL COMBINATION CONTAINING (A) FORMOTEROL, OR A SALT, OR A SOLVATE OF IT OR THE SALT AND (B) MOMETASONE FUROATE; PHARMACEUTICAL CASE THAT UNDERSTANDS IT; AND ITS USE IN THE THERAPY OF AN INFLAMMATORY OR OBSTRUCTIVE DISEASE OF THE V | |
| ES2052603T3 (en) | DERIVATIVES OF BENCIMIDAZOLE, PROCEDURE FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION THAT CONTAIN THEM. | |
| DE60105448D1 (en) | SOLID DISPERSIONS WITH NITRATIVE ACTIVE INGREDIENTS | |
| PE20011005A1 (en) | COMBINATIONS OF A PHOSPHODIESTERASE 4 INHIBITOR AND A STEROID ANTI-INFLAMMATORY FOR THE TREATMENT OF PULMONARY DISEASES | |
| ES2152670T3 (en) | DERIVATIVES OF NITRITE AND NITRATE USEFUL STEROIDS AS ANTI-INFLAMMATORY PHARMACOS. | |
| PE20040068A1 (en) | ETONOGESTREL DECANOATE, UNDECANOATE AND DODECANOATE | |
| GT200100201A (en) | DERIVATIVES OF PIRAZOL FOR THE TREATMENT DER VIRIC DISEASES. | |
| CR6824A (en) | ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRIPTASE INHIBITORS | |
| PT912185E (en) | NEW PHARMACEUTICAL FORMULATIONS CONTAINING ESTER NITRATE DERIVATIVES FROM PROVIDED ESTEROIDS AS ANTI-INFLAMMATORY DRUGS | |
| MX9304503A (en) | ANTI-INFLAMMATORY COMPOUNDS. | |
| ECSP034470A (en) | 6.ALFA., 9.ALFA-DIFLUOR-17.ALFA.- (2-FURANILCARBOXILO) OXY-11.BETA.-HIDROXI-16.ALFA.-METIL-3-OXO-ANDROST-1,4, -DIENE- 17-S-FLUORMETILE ESTER CARBOTIOTIC ACID AS AN ANTI-INFLAMMATORY AGENT | |
| ES2165948T3 (en) | THERMOSTABLE CRYSTAL MODIFICATION AND SUITABLE FOR STORAGE OF N-METHYL-N - ((1S) -1-PHENYL-2 - ((3S) -3-HIDROXI-PIRROLIDIN-1-IL) -ETIL) -2,2-DIFENIL- ACETAMIDE, AND PROCEDURE FOR OBTAINING. | |
| IL164159A0 (en) | C-17 spirolactonization and 6,7 oxidation of steroids | |
| WO2004094373A3 (en) | A method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith | |
| AR028986A1 (en) | USE OF A PDE4 INHIBITOR IN THE MANUFACTURE OF A CONTROLLED LIBERATION PREPARATION; FORMULATION OF CONTROLLED RELEASE FOR THE TREATMENT OF COPD, A PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION | |
| ES2166549T3 (en) | PREPARATION PROCEDURE FOR 17-ESTERES OF 9ALFA, 21-DIHALO-PREGNAN-11BETA, 17ALFADIOL-20-ONAS. | |
| CL2019003562A1 (en) | Steroid derivatives with therapeutic activity. | |
| MX2024009773A (en) | PHARMACEUTICAL COMPOSITION INCLUDING DIPHENYLDIAZOLE DERIVATIVES AND METHODS OF USE. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |